New York State has expanded COVID-19 vaccine eligibility to people with certain medical conditions, which includes liver disease (such as hepatitis B, hepatitis C, cirrhosis or other liver disease).
General News
The NYC Department of Health has noted a recent increase in reports of hepatitis A among people who use drugs, are homeless or unstably housed, or are in methadone programs in NYC. Hep A can lead to severe illness and death, particularly in people with underlying health condition...
Organizations wishing to receive City Council funding in FY 2022 must complete Discretionary Funding application by February 19, 2021.
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
The Hepatitis A, B and C in NYC: 2019 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
The NYS Viral Hepatitis Strategic Plan outlines a coordinated, comprehensive, and systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
The new CDC algorithm for testing and treating pregnant women for hepatitis B The PHBPP Perinatal Algorithm has been finalized and is now posted on the Division of Viral Hepatitis webpage. The link is below: https://www.cdc.gov/hepatitis/hbv/perinatalxmtn.htm Here you will find...
In March 2020, the United States Preventive Services Task Force recommended one-time screening for hepatitis C in people aged 18-79. Simplified treatment guidance has been developed for hepatitis B and C.
Hep Free NYC is launching a capacity building initiative to support partners to implement hepatitis B and C telehealth services.
COVID-19 "Coronavirus" Community & NYC Hep Service Provider Resources
